Evaluation of Ceftazidime/Avibactam Administration in Enterobacteriaceae and Pseudomonas aeruginosa Bloodstream Infections by Monte Carlo Simulation.
Yuanyuan DaiWenjiao ChangXin ZhouWei YuChen HuangYunbo ChenXiaoling MaHuaiwei LuRujin JiChaoqun YingPeipei WangZhiying LiuQingfeng YuanYonghong XiaoPublished in: Drug design, development and therapy (2021)
CZA has good antibacterial activity against Enterobacteriaceae and P. aeruginosa in bloodstream infections. Clinicians could make individualized treatment regimens in accordance with the sensitivity of the strains and the level of renal function in their patients to best predict the drug-related clinical responses.
Keyphrases
- pseudomonas aeruginosa
- end stage renal disease
- multidrug resistant
- monte carlo
- klebsiella pneumoniae
- cystic fibrosis
- ejection fraction
- newly diagnosed
- gram negative
- chronic kidney disease
- escherichia coli
- biofilm formation
- prognostic factors
- acinetobacter baumannii
- peritoneal dialysis
- urinary tract infection
- drug resistant
- adverse drug
- smoking cessation